Mode
Text Size
Log in / Sign up

Oncology

1582 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Non-targeted effects and signaling factors may influence DNA damage and repair in radiation therapy
Oncology Sys. Review
Non-targeted effects and signaling factors may influence DNA damage and repair in radiation therapy Radiation can cause DNA damage in cells not hit directly
This narrative review explores the mechanisms of non-targeted effects (NTEs) and inter-individual signaling in radiation therapy. The author…
New research shows that radiation can damage DNA in cells that were not directly hit, potentially changing how we design cancer treatments.
Conservative Management Favored for Pediatric Epididymal Cysts; Routine Prolonged Ultrasound Surveillance Questioned
Oncology Meta-analysis
Conservative Management Favored for Pediatric Epididymal Cysts; Routine Prolonged Ultrasound Surveillance Questioned Conservative Management Options for Pediatric Epididymal Cysts
This meta-analysis of 492 males younger than 18 years with epididymal cysts found that 12.2% experienced complete spontaneous regression and…
New data suggests a conservative first approach for children with epididymal cysts, as many cases resolve on their own without needing surge…
HPV testing reduces CIN2+ detection risk to 0.44 hazard ratio compared to cytology
Oncology RCT
HPV testing reduces CIN2+ detection risk to 0.44 hazard ratio compared to cytology HPV Testing Improves Detection of Cervical Cancer Pre-Cancer Lesions in Older Women
This randomized trial of 6471 women aged 50 and older found that HPV testing was more effective than cytology for CIN2+ detection. The study…
New testing methods show that checking for HPV is more effective than standard cell checks for finding serious cervical issues in women over…
Histopathology and methylome profiling confirm metastatic recurrence 13 years after curative treatment for GEJA
Oncology Sys. Review
Histopathology and methylome profiling confirm metastatic recurrence 13 years after curative treatment for GEJA A brain tumor appears 13 years after cancer treatment
This case report and literature review describes a patient with gastroesophageal junction adenocarcinoma who presented with a solitary brain…
A patient and doctors discovered a brain tumor over a decade after they had successfully treated her esophageal cancer.
Structured framework sets 16 quality indicators for animal cancer registries
Oncology Sys. Review
Structured framework sets 16 quality indicators for animal cancer registries New framework helps improve the quality of animal cancer data
This systematized literature review proposes a structured quality assessment framework for animal cancer registries, adapted from internatio…
A new assessment tool helps researchers ensure animal cancer records are accurate and consistent across different locations.
Phase 3 monotherapy trials show superior objective response rates and survival in solid malignancies
Oncology Meta-analysis
Phase 3 monotherapy trials show superior objective response rates and survival in solid malignancies Phase 3 trials show better survival rates for solid malignancies
This meta-analysis compared monotherapy drug trials in phase 2 and phase 3 for patients with solid malignancies. The findings indicate that …
Patients with solid tumors may see better survival and response rates in phase 3 trials compared to earlier phase 2 trials.
Chemotherapy-Free Ponatinib Plus Blinatumomab Beats Imatinib in Ph-Positive ALL
Oncology RCT
Chemotherapy-Free Ponatinib Plus Blinatumomab Beats Imatinib in Ph-Positive ALL Trial shows ponatinib and blinatumomab improve outcomes for Philadelphia-positive ALL
In Ph-positive ALL, frontline ponatinib plus blinatumomab achieved 86% 24-month event-free survival versus 67% with imatinib plus chemothera…
A new combination of ponatinib and blinatumomab showed higher survival rates and fewer relapses for adults with Philadelphia-positive ALL.
Multimodal data integration improves progression risk prediction in hormone receptor positive metastatic breast cancer
Oncology Phase III
Multimodal data integration improves progression risk prediction in hormone receptor positive metastatic breast cancer Machine Learning Improves Prediction of Breast Cancer Progression
Researchers analyzed clinical, genomic, and ctDNA data to predict progression free survival in patients with advanced breast cancer. The stu…
A new machine learning model combines clinical and genetic data to better predict how quickly metastatic breast cancer may progress.
Erector spinae plane block reduces morphine consumption and extends analgesia duration in breast cancer surgery
Oncology Meta-analysis
Erector spinae plane block reduces morphine consumption and extends analgesia duration in breast cancer surgery Nerve Block May Reduce Pain and Opioid Use in Breast Surgery
This meta-analysis evaluates the efficacy of uni-level erector spinae plane block (ESPB) for pain management in breast cancer surgery patien…
A specific nerve block may help reduce pain and lower the amount of opioids needed for patients recovering from breast cancer surgery.
Glutamine metabolism serves as a critical energy substrate and potential therapeutic target in AKI and CKD
Oncology Sys. Review
Glutamine metabolism serves as a critical energy substrate and potential therapeutic target in AKI and CKD Glutamine Metabolism May Offer New Insights for Kidney Disease
This narrative review explores the role of glutamine metabolism in acute kidney injury and chronic kidney disease. The authors suggest that …
New research into glutamine metabolism suggests potential new ways to manage and treat acute and chronic kidney diseases.
18F-FDG PET/CT SUVmax and TLR are associated with increased microvascular invasion risk in HCC
Oncology Meta-analysis
18F-FDG PET/CT SUVmax and TLR are associated with increased microvascular invasion risk in HCC PET Imaging Biomarkers Help Predict Liver Cancer Risks
This meta-analysis of 2,023 patients evaluates 18F-FDG PET/CT imaging biomarkers for predicting microvascular invasion in hepatocellular car…
New analysis shows specific PET imaging markers can help doctors predict microvascular invasion in patients with hepatocellular carcinoma.
YAP and TAZ Overexpression Predicts Worse Survival in Oral Squamous Cell Carcinoma
Oncology Meta-analysis
YAP and TAZ Overexpression Predicts Worse Survival in Oral Squamous Cell Carcinoma Hippo Pathway Markers Linked to Oral Cancer Survival Rates
This meta-analysis of 17 studies examined the prognostic value of Hippo pathway effectors YAP and TAZ in oral squamous cell carcinoma. Poole…
New data suggests that specific proteins in the Hippo pathway may help predict survival outcomes for patients with oral squamous cell carcin…